Nyumbani › Mesothelioma
Majaribio ya kliniki ya Mesothelioma yanayovutia washiriki nchini Marekani
Masomo 45 ya Mesothelioma yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Houston, TXUtafiti 15
- New York City, NYUtafiti 10
- Washington, DCUtafiti 9
- Chicago, ILUtafiti 9
- Nashville, TNUtafiti 8
- Boston, MAUtafiti 8
- Arlington, VAUtafiti 6
- Philadelphia, PAUtafiti 6
- Pittsburgh, PAUtafiti 6
- Seattle, WAUtafiti 6
- Los Angeles, CAUtafiti 6
- Rochester, MNUtafiti 5
- Columbus, OHUtafiti 5
- Edison, NJUtafiti 5
- San Antonio, TXUtafiti 4
- San Diego, CAUtafiti 4
- St. Louis, MOUtafiti 4
- Tampa, FLUtafiti 4
- Jacksonville, FLUtafiti 4
- Phoenix, AZUtafiti 4
- Queens, NYUtafiti 4
- Dallas, TXUtafiti 4
- Omaha, NEUtafiti 4
- Grand Rapids, MIUtafiti 3
- Denver, COUtafiti 3
- Detroit, MIUtafiti 3
- Santa Monica, CAUtafiti 3
- Mountain View, CAUtafiti 3
- Greenburgh, NYUtafiti 3
- New Rochelle, NYUtafiti 3
- East Norwalk, CTUtafiti 3
- Staten Island, NYUtafiti 3
- Miami, FLUtafiti 3
- Santa Rosa, CAUtafiti 3
- Durham, NCUtafiti 3
- Fort Worth, TXUtafiti 3
Kwa jimbo
- ArizonaUtafiti 7
- CaliforniaUtafiti 12
- ColoradoUtafiti 8
- FloridaUtafiti 12
- GeorgiaUtafiti 3
- IllinoisUtafiti 11
- KansasUtafiti 3
- MarylandUtafiti 10
- MassachusettsUtafiti 10
- MichiganUtafiti 6
- MinnesotaUtafiti 8
- MissouriUtafiti 5
- NebraskaUtafiti 4
- New JerseyUtafiti 8
- New YorkUtafiti 11
- North CarolinaUtafiti 4
- OhioUtafiti 9
- PennsylvaniaUtafiti 13
- TennesseeUtafiti 8
- TexasUtafiti 19
- UtahUtafiti 4
- VirginiaUtafiti 8
- WashingtonUtafiti 6
- WisconsinUtafiti 3
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
SW-682 in Advanced Solid Tumors
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06251310Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
InaajiriUtafiti wa uchunguzi
Umri 2 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT00242723Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
InaajiriUtafiti wa uchunguzi
Umri 2 hadi 100 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT01950572Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06885697Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
InaajiriUtafiti wa uchunguzi
Umri 2 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT03830229Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
InaajiriHatua 1/2Wajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05932199Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 30 hadi 120 · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT04431024A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT04981119Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Inaajiri
Umri 30 hadi 85 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06037941A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06057935Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
InaajiriHatua 2
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT05960773A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT06566079TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT05245500A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT04104776Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
InaajiriHatua 1
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT07192900Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
InaajiriHatua 1/2
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 6 Jul 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 19 hadi 110 · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Jun 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Jun 2026 · NCT06756035A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Jun 2026 · NCT06051695Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.